Novartis (NVS)

Add to Watchlists
Create an Alert
87.11 +0.38  +0.44% NYSE Jan 17, 13:29 Delayed 2m USD

Novartis Enterprise Value:

225.38B for Jan. 16, 2018
View 4,000+ financial data types
Browse...
View Full Chart

Novartis Enterprise Value Chart

Export Data
Save Image
Print Image

Novartis Historical Enterprise Value Data

View and export this data going back to 1995. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Jan. 16, 2018 225.38B
Jan. 12, 2018 225.20B
Jan. 11, 2018 222.90B
Jan. 10, 2018 223.34B
Jan. 9, 2018 224.54B
Jan. 8, 2018 224.19B
Jan. 5, 2018 224.30B
Jan. 4, 2018 222.31B
Jan. 3, 2018 222.13B
Jan. 2, 2018 220.58B
Dec. 29, 2017 218.89B
Dec. 28, 2017 219.57B
Dec. 27, 2017 218.61B
Dec. 26, 2017 216.90B
Dec. 22, 2017 216.53B
Dec. 21, 2017 217.79B
Dec. 20, 2017 216.76B
Dec. 19, 2017 220.70B
Dec. 18, 2017 221.49B
Dec. 15, 2017 221.00B
Dec. 14, 2017 220.09B
Dec. 13, 2017 220.53B
Dec. 12, 2017 220.06B
Dec. 11, 2017 218.52B
Dec. 8, 2017 218.89B
   
Dec. 7, 2017 216.36B
Dec. 6, 2017 217.07B
Dec. 5, 2017 218.61B
Dec. 4, 2017 221.05B
Dec. 1, 2017 223.79B
Nov. 30, 2017 223.20B
Nov. 29, 2017 221.68B
Nov. 28, 2017 222.20B
Nov. 27, 2017 220.20B
Nov. 24, 2017 221.52B
Nov. 22, 2017 220.11B
Nov. 21, 2017 219.64B
Nov. 20, 2017 217.16B
Nov. 17, 2017 218.94B
Nov. 16, 2017 216.69B
Nov. 15, 2017 215.71B
Nov. 14, 2017 216.71B
Nov. 13, 2017 215.96B
Nov. 10, 2017 215.19B
Nov. 9, 2017 215.43B
Nov. 8, 2017 216.50B
Nov. 7, 2017 215.21B
Nov. 6, 2017 217.82B
Nov. 3, 2017 218.28B
Nov. 2, 2017 216.13B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

NVS Enterprise Value Benchmarks

Benchmarks
Roche Holding 226.85B
AstraZeneca 102.94B
Celgene 85.04B

NVS Enterprise Value Range, Past 5 Years

Minimum 169.39B Jan 22 2013
Maximum 273.77B Jul 20 2015
Average 216.17B

NVS Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("NVS", "enterprise_value")
  • Last 5 data points: =YCS("NVS", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.